Design Therapeutics (DSGN) Other Working Capital Changes (2020)

Design Therapeutics (DSGN) has 7 years of Other Working Capital Changes data on file, last reported at $287000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes fell 79.6% year-over-year to $287000.0; the trailing twelve-month figure through Mar 2026 stood at $256000.0 (down 66.75% YoY), and the FY2025 full-year result was $1.4 million, up 708.85% from the prior year.
• Other Working Capital Changes was little changed at $300000.0 in Q1 2020.
• In the past five years, Other Working Capital Changes ranged from a high of $1.9 million in Q3 2022 to a low of -$1.2 million in Q1 2023.
• A 5-year average of $168000.0 and a median of $287000.0 in 2026 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes surged 508.15% in 2022 and sank 274.73% in 2023, its largest moves.
• Tracing DSGN's Other Working Capital Changes over 5 years: stood at $471000.0 in 2022, then slumped by 274.73% to -$823000.0 in 2023, then increased by 26.49% to -$605000.0 in 2024, then jumped by 245.45% to $880000.0 in 2025, then plunged by 67.39% to $287000.0 in 2026.
• Business Quant data shows DSGN's Other Working Capital Changes at $287000.0 in Q1 2026, $880000.0 in Q4 2025, and -$459000.0 in Q3 2025.